Delivery Order SPE2DB24D1021-SPE2DB25FFAQP
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $62,937.18 delivery order from the Defense Logistics Agency (DLA) for 90 tablets of Jardiance 25 mg on July 22, 2025, with an ultimate completion date of July 23, 2025. The award was made under firm fixed-price terms with no set-aside designation, indicating it was competitively awarded. This delivery order is issued as a child contract under AmerisourceBergen's substantial...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, has been awarded a delivery order by the Defense Logistics Agency (DLA) for 90-count bottles of Jardiance 10 mg tablets, valued at $22,225.71. This competitively awarded, firm fixed-price delivery order was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The contract carries no set-aside designation and represents a continuation of the vendor's...
- AmerisourceBergen Drug Corp was awarded a delivery order on August 8, 2025, for the supply of Jardiance 10mg tablets (90-count) to the Defense Logistics Agency's Medical Supply Chain. The contract is valued at $11,479.71 with a firm fixed price structure and is scheduled for completion by September 5, 2025. This is a competitive award with no set-aside designation, and the place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on August 7, 2025, for the supply of Jardiance 25 mg tablets (90-count units) with a firm fixed price ceiling value of $4,328.80 and an ultimate completion date of August 8, 2025. This award represents a non-competitive set-aside delivery order under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a comprehensive...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $18,630.72 by the Defense Logistics Agency (DLA) for the supply of Jardiance 25 mg tablets in quantities of 90 units. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 12, 2025, with performance taking place at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was issued on August 11, 2025, under a non-set-aside procurement. This delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on August 15, 2025, by the Defense Logistics Agency's Medical Supply Chain to supply Jardiance 10 mg tablets (90-count packaging). The contract carries a ceiling value of $48,577.98 and employs firm fixed price terms with an ultimate completion date of August 18, 2025. This non-set-aside award was competitively awarded and represents a child delivery order...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,684.94 by the Defense Logistics Agency (DLA) on July 30, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of July 31, 2025. The contract represents a child delivery order under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order on September 10, 2025, by the Defense Logistics Agency (DLA) to supply 90 tablets of Jardiance 10 mg medication. This competitively awarded, non-set-aside contract carries a ceiling value of $36,770.17 and is scheduled for completion by September 11, 2025. The award represents a single delivery order under AmerisourceBergen's broader Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a $4,881.13 firm fixed-price delivery order from the Defense Logistics Agency on August 11, 2025, for Jardiance 25 mg tablets (90-count supply). The contract, which is non-set-aside and competitively awarded, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999.00 through December...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $12,130.81 on July 31, 2025, for the supply of Jardiance 25 mg tablets (90-count units). This firm fixed-price, competitively awarded contract has an ultimate completion date of August 1, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFAQPDelivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, received a firm fixed-price delivery order from the Defense Logistics Agency for 30 tablets of Jardiance 10 mg, with a ceiling value of $10,510.63 and an ultimate completion date of September 15, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The delivery order was competitively awarded without set-aside designation, consistent with the company's established track record of fulfilling federal medical procurement requirements. This delivery order falls within the scope of DLA's comprehensive pharmaceutical supply chain operations, which support military healthcare systems and the Defense Health Agency. Jardiance, a diabetes medication, exemplifies the range of therapeutic categories that AmerisourceBergen supplies through its federal contracts, including specialty medications, brand-name and generic pharmaceuticals, and medical supplies. The award demonstrates the company's role as a critical vendor in the federal medical supply procurement process, fulfilling specific pharmaceutical needs for military and veteran healthcare systems through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.5k | 9/12/25 |